General
Preferred name
Iron sucrose
Synonyms
P&D ID
PD009029
Tags
contains metal
drug
Drug Status
approved
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
ROE Renal elimination of iron contributed very little to the total elimination (in average less than 5%).; While, renal elimination of sucrose accounts for 68-75% of the administered dose after 4 and 24 hours respectively.
TOXICITY Hypersensitivity reactions, including anaphylactic shock, loss of consciousness, collapse, hypotension, dyspnea, and seizure.; Monitor iron toxicity through the periodic evaluation of lab works which monitor the body concentration of iron. Lab monitoring of the following parameters: transferrin saturation, serum ferritin concentrations, hemoglobin, and hematocrit could be helpful to avoid iron overload.; Severe allergic symptoms include: rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness); burning or pain at the injection site; burning, numbness, or tingling; chest pain; fainting; loss of consciousness; severe or persistent dizziness, headache, or light-headedness; seizures; shortness of breath; swelling of the hands, ankles, or feet.
Compound Sets
2
DrugBank
DrugBank Approved Drugs
External IDs
2
Properties
(calculated by RDKit )
Molecular Weight
866.76
Hydrogen Bond Acceptors
12
Hydrogen Bond Donors
8
Rotatable Bonds
5
Ring Count
2
Aromatic Ring Count
0
cLogP
-15.0
TPSA
542.03
Fraction CSP3
1.0
Chiral centers
9.0
Largest ring
6.0
QED
0.12
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Source data